認知症うつ：ジェイゾロフト・リフレックス無効
2011年 07月 20日
ジェイゾロフト（セルトラリン・サートラリン：sertraline）とリフレックス（ミルタザピン：Mirtazapine)は認知症うつに対し無効
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial
The Lancet, Early Online Publication, 18 July 2011doi:10.1016/S0140-6736(11)60830-1Cite or Link Using DOI
Unadjusted mean CSDD scores by treatment group
Lowest score is best. Error bars show 95% CIs. CSDD=Cornell scale for depression in dementia.
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial
The Lancet, Early Online Publication, 18 July 2011doi:10.1016/S0140-6736(11)60830-1Cite or Link Using DOI
Unadjusted mean CSDD scores by treatment group
Lowest score is best. Error bars show 95% CIs. CSDD=Cornell scale for depression in dementia.
by internalmedicine | 2011-07-20 10:22
